Harvest Fund Management Co., LTD Guardant Health, Inc. Transaction History

Harvest Fund Management Co., LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$16.07 - $31.84 $53,529 - $106,059	3,331 New	3,331 $96,000
Q3 2023 Nov 06, 2023	SELL	$25.8 - $39.97 $2,631 - $4,076	-102 Reduced 42.15%	140 $4,000
Q2 2023 Jul 07, 2023	BUY	$20.94 - $38.01 $5,067 - $9,198	242 New	242 $9,000
Q2 2021 Aug 11, 2021	SELL	$109.77 - $165.68 $10,757 - $16,236	-98 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $12,449 - $17,551	98 New	98 $14,000
Q1 2020 May 08, 2020	SELL	$59.04 - $88.81 $38,435 - $57,815	-651 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $38,727 - $53,889	651 New	651 $52,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.